Dr. Naveen Garg

Family Medicine
99 Woodland St, 
Hartford, CT 
 (701.2 mi)
99 Woodland St, 
Hartford, CT 
 (701.2 mi)
OverviewInsuranceLocationsClinical Research

Overview

Naveen Garg is a Family Medicine provider in Hartford, Connecticut. His top areas of expertise are H1N1 Influenza and Parainfluenza.

His clinical research consists of co-authoring 1 peer reviewed article and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Family Medicine
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Locations

99 Woodland St, Hartford, CT 06105

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
A Phase 3, Randomized, Placebo-controlled, Observer-blind, Multi-country Study to Demonstrate the Efficacy of a Single Dose and Annual Revaccination Doses of GSK's RSVPreF3 OA Investigational Vaccine in Adults Aged 60 Years and Above
Enrollment Status: Completed
Publish Date: October 08, 2024
Intervention Type: Biological
Study Drug: RSVPreF3
Study Phase: Phase 3
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
A Phase III, Randomized, Controlled, Observer-blind Study to Demonstrate Effectiveness, Immunogenicity and Safety of GSK's Meningococcal Group B and Combined ABCWY Vaccines When Administered to Healthy Adolescents and Young Adults
Enrollment Status: Completed
Publish Date: March 05, 2024
Intervention Type: Combination product, Biological
Study Phase: Phase 3
A Phase III, Randomized, Multi-country Study to Evaluate the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response, Safety and Reactogenicity of RSV Maternal Vaccine When Co-administered With GSK's Quadrivalent Influenza D-QIV Vaccine in Healthy Non-pregnant Women 18-49 Years of Age.
A Phase III, Randomized, Multi-country Study to Evaluate the Lot-to-lot Consistency of GSK's Investigational RSV Maternal Vaccine and the Immune Response, Safety and Reactogenicity of RSV Maternal Vaccine When Co-administered With GSK's Quadrivalent Influenza D-QIV Vaccine in Healthy Non-pregnant Women 18-49 Years of Age.
Enrollment Status: Completed
Publish Date: October 05, 2023
Intervention Type: Combination product
Study Phase: Phase 3
A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85
A Phase I/II, First-in-human, Observer-blinded, Randomized, Placebo-controlled, Parallel Group Study to Evaluate the Safety and Immunogenicity of TAP-COVID-19 SARS-CoV-2 Vaccine With CpG Adjuvant in Healthy Adults Aged 18-49 and 50-85
Enrollment Status: Completed
Publish Date: October 03, 2023
Intervention Type: Biological
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

1 Total Publications

Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
Phase 1, randomized, rater and participant blinded placebo-controlled study of the safety, reactogenicity, tolerability and immunogenicity of H1N1 influenza vaccine delivered by VX-103 (a MIMIX microneedle patch [MAP] system) in healthy adults.
Journal: PloS one
Published: December 07, 2023
Similar Doctors
Peter L. Anderson
Expertise in
11
conditions
Dr. Peter L. Anderson
Family Medicine
Expertise in
11
conditions
Dr. Peter L. Anderson
Family Medicine

Nuvance Health Medical Practice Ct Inc

1 Old Park Lane Rd, 
New Milford, CT 
 (38.4 mi)
860-355-3728
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Peter Anderson is a Family Medicine provider in New Milford, Connecticut. Dr. Anderson is highly rated in 11 conditions, according to our data. His top areas of expertise are HIV/AIDS, Acute Kidney Failure, Ascites, and Hypertension.

Expertise in
9
conditions
Dr. Cristina Calin
Family Medicine
Expertise in
9
conditions
Dr. Cristina Calin
Family Medicine

Hartford Healthcare Medical Group Inc

445 S Main St, 
West Hartford, CT 
 (3.7 mi)
860-696-2200
Languages Spoken:
English, French, Romanian
See accepted insurances
Accepting New Patients

Cristina Calin is a Family Medicine provider in West Hartford, Connecticut. Dr. Calin is highly rated in 9 conditions, according to our data. Her top areas of expertise are Premature Ovarian Failure, Infertility, Hypogonadism Primary Partial Alopecia, and Familial Hypertension. Dr. Calin is currently accepting new patients.

Expertise in
17
conditions
Dr. Stacy J. Taylor
Family Medicine
Expertise in
17
conditions
Dr. Stacy J. Taylor
Family Medicine

Asylum Hill Family Medicine Center, Inc.

893 Main St, Suite 101, 
East Hartford, CT 
 (2.9 mi)
860-528-2138
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Stacy Taylor is a Family Medicine provider in East Hartford, Connecticut. Dr. Taylor is highly rated in 17 conditions, according to our data. Her top areas of expertise are Folate Deficiency, Multiple Carboxylase Deficiency, Vitamin B12 Deficiency Anemia, and Subacute Combined Degeneration.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile